Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Lilly sells two legacy antibiotics and manufacturing facility to Eddingpharm for $375mm

Executive Summary

Eli Lilly & Co. sold two of its legacy antibiotics--Ceclor (cefaclor) and Vancocin (vancomycin)--plus a Ceclor manufacturing facility in Suzhou, China to Eddingpharm International Holdings Ltd.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Product Purchase

Related Companies